IL-33 in Rheumatic Diseases.
IL-33 in Rheumatic Diseases.
复制标题
IL-33 在风湿性疾病中的作用
DOI:
10.3389/fmed.2021.739489
复制
发表时间:
2021
影响因子:
3.9
通讯作者:
Dong L
中科院分区:
文献类型:
--
作者:
Dong Y;Zhong J;Dong L
Interleukin-33 (IL-33) is a nuclear factor mainly expressed in barrier epithelium, endothelial cells, and fibroblast reticular cells. Some inflammatory cells also express IL-33 under certain conditions. The important role of IL-33 in allergic reactions, helminth infection, cancer, tissue fibrosis, chronic inflammation, organ transplantation, and rheumatic immune diseases has been extensively studied in recent years. IL-33 primarily activates various circulating and tissue-resident immune cells, including mast cell, group 2 innate lymphoid cell (ILC2), regulatory T cell (Treg), T helper 2 cell (Th2), natural killer cell (NK cell), and macrophage. Therefore, IL-33 plays an immunomodulatory role and shows pleiotropic activity in different immune microenvironments. The IL-33/serum stimulation-2 (ST2) axis has been shown to have a detrimental effect on rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic diseases. Interestingly, IL-33 also plays a protective role in the repair of barrier epithelium and the activation of Tregs. Therefore, the role of IL-33/ST2 depends on the underlying pathological conditions in rheumatic diseases. This review focuses on the dual role of the IL-33/ST2 axis in rheumatic diseases.
登录
查看更多内容
DOI:
10.1073/pnas.0812690106
发表时间:
2009-06-02
影响因子:
11.1
作者:
Cayrol, Corinne;Girard, Jean-Philippe
通讯作者:
Girard, Jean-Philippe
影响因子:
7.7
作者:
Clark JT;Christian DA;Gullicksrud JA;Perry JA;Park J;Jacquet M;Tarrant JC;Radaelli E;Silver J;Hunter CA
通讯作者:
Hunter CA
影响因子:
24.1
作者:
通讯作者:
--
影响因子:
81.5
作者:
Brito-Zeron, Pilar;Baldini, Chiara;Ramos-Casals, Manuel
通讯作者:
Ramos-Casals, Manuel
影响因子:
6.7
作者:
Fattori, Victor;Staurengo-Ferrari, Larissa;Verri Jr, Waldiceu A.
通讯作者:
Verri Jr, Waldiceu A.